ANDA 219472, held by Emerge Bioscience. Selenious Acid.
As of Nov 16, 2026, ANDA 219472 (Selenious Acid), held by Emerge Bioscience, was first approved by FDA on Feb 3, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 3, 2026 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Selenious AcidEQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) ยท solution;intravenous | Selenious Acid | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters